By Cindy Atoji
 |
| Andrew Mellin |
Oct.7, 2008 | McKesson is jockeying for a prominent position in the rapidly evolving personalized medicine race, developing capabilities for next-generation electronic health records (EHRs), says
Andrew Mellin, vice president for Predictive Care Solutions. The San Francisco-based health care giant formed this new group last year within the Life Sciences division, focusing in particular on tweaking its Horizon Clinicals products—decision support and physician order entry—to support advancements in genomics, genetic testing, and bioinformatics as they emerge. “We view ourselves as a catalyst of personalized medicine,” says Mellin, who spoke to Digital HealthCare & Productivity about the company’s recent partnership with Proventys, and its strategies for personalized medicine....
Read more.